Akebia Therapeutics, Inc. · NASDAQ:AKBA
The Vanguard Group reported a 5.37% stake in Akebia Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2025 · Filed Apr 30, 2025
The Vanguard Group reported a 5.37% stake in Akebia Therapeutics, Inc., 12,685,803 shares, as a passive investor on Mar 31, 2025. Filed Apr 30, 2025 (Schedule 13G).
- Stake
- 5.37%
- Shares
- 12,685,803
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 5.37% | 12,685,803 |
Source
Related
- Akebia Therapeutics, Inc.
- The Vanguard Group
- Akebia Therapeutics, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Form 4 · Butler John P. · Aug 10, 2026
- Form 4 · Ostrowski Erik · Jul 1, 2026
- Form 4 · Wolf Myles · Jun 22, 2026
- Form 4 · Smith Cynthia · Jun 22, 2026
- Form 4 · Rogers Michael W · Jun 22, 2026